Drug intelligence / Profile preview

clomiphene citrate + gonadotropins

Development stage
Unknown
Lead developer
Sanofi
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral, Intramuscular, Subcutaneous
01

Overview

Clomiphene citrate + gonadotropins is a combination therapy used primarily in the treatment of female infertility, especially for ovulation induction in women who do not ovulate regularly or are resistant to clomiphene alone. Clomiphene citrate is a selective estrogen receptor modulator (SERM) that acts on the hypothalamus and pituitary to increase secretion of endogenous follicle-stimulating hormone (FSH) and luteinizing hormone (LH), thereby stimulating ovarian follicular development and ovulation[6][7][9]. Gonadotropins are injectable hormones—typically FSH, LH, or human menopausal gonadotropin (hMG)—that directly stimulate the ovaries to promote follicular growth and maturation. The combination is often used in assisted reproductive technologies such as controlled ovarian stimulation for in vitro fertilization (IVF) or intrauterine insemination (IUI), particularly when monotherapy with either agent is insufficient[1][2][5]. This regimen may reduce medication costs and lower risks of ovarian hyperstimulation syndrome compared to high-dose gonadotropin protocols but can be associated with increased cycle cancellation rates and reduced oocyte yield[5].

Other names
clomiphene + gonadotropinsCC + gonadotropins
02

Targets

ER (Estrogen receptor)LHCGR (Luteinizing hormone/choriogonadotropin receptor)FSHR (Follicle-stimulating hormone receptor)

Beyond the preview

Go deeper on clomiphene citrate + gonadotropins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clomiphene citrate + gonadotropins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call